Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00892333 · ClinicalTrials.gov registry record
Large Abdominal Hernia Repair With SurgiMend 3.0
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 122
- Enrollment target
NCT00892333 is a clinical trial that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 122 participants.
The verdict
NCT00892333 has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 122 participants
- Enrollment target
Study Summary
The rate of hernia recurrence at one year following repair of a large abdominal hernia with a biologic mesh is high, ranging from 30% to 100%, with a reported historic average rate of 40%. The purpose of this study is to evaluate the rate of hernia recurrence at one year following repair with SurgiMend 3.0, an FDA-cleared novel biologic mesh, the hypothesis being that such rate will be less than 20% at one year, representing a 50% reduction over the historic rate of 40%.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00892333
The ClinicalTrials.gov registry entry for NCT00892333 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00892333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00892333 about?
NCT00892333 is a clinical study titled "Large Abdominal Hernia Repair With SurgiMend 3.0". The rate of hernia recurrence at one year following repair of a large abdominal hernia with a biologic mesh is high, ranging from 30% to 100%, with a reported historic average rate of 40%. The purpose of this study is to evaluate the rate of hernia recurrence at one year following repair with SurgiM...
What is the current status of trial NCT00892333?
This trial is currently completed. The enrollment target is 122 participants. The study started on 2009-04. Estimated completion is 2014-07.
Who is sponsoring clinical trial NCT00892333?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.